NETest News

Our liquid biopsy-based NETest is performed at our CLIA-certified clinical laboratory in Branford, CT. Large healthcare organizations have added it to their formulary; below is just some of the recent press coverage.
NETest

NETest proven effective in monitoring PRRT

Blood-based genomic assessment is 90% accurate in predicting PRRT treatment response for NETs.

Read ArticleRead Article
NETest

Clinical Utility of Multigene Blood Analysis

NETest is 4X more precise than CgA and 10X more precise for monitoring disease progress.

Read ArticleRead Article
NETest

NETest shows blood viable for tumor monitoring

Wren Lab’s liquid biopsy has proven an effective biomarker for cancer treatment decision-making.

Read ArticleRead Article
NETest

Blood test predicts NET cancer therapy success

Noninvasive NETest-type diagnostics predict therapy success and provide therapy monitoring.

Read ArticleRead Article
NETest

NETest possible predictor of tumor recurrence

NETest is a highly accurate post-operative predictor of neuroendocrine tumor recurrence.

Read ArticleRead Article